Episode 20 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 4 - Clinical Data Deep Dive - What Clinical Trials Tell Us
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
Episode 20 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 4 - Clinical Data Deep Dive - What Clinical Trials Tell Us
-
Lu par :
-
De :
À propos de ce contenu audio
Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk.
Launch Date: August 25, 2025
Release Date: August 25, 2025
Expiration Date: July 31, 2026
FACULTY
C. Michael Gibson, MD, MS, MA, FRCP, FAHA, FSCAI, FACC
Interventional Cardiologist
Beth Israel Lahey
CEO
Baim Institute for Clinical Research
Professor of Medicine
Harvard Medical School
Manesh Patel, MD
Richard Sean Stack, M.D. Distinguished Professor
Professor of Medicine
Chief, Division of Cardiology
Duke University Health System
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !